Kaufmann M - Search Results

1

Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum.

Fritze D, Massner B, Becher R, Kaufmann M, Illiger HJ, Hartlapp J, Queisser W, Abel U, Edler L, Mayr AC, et al. Fritze D, et al. Among authors: kaufmann m. Klin Wochenschr. 1984 Feb 15;62(4):162-7. doi: 10.1007/BF01731638. Klin Wochenschr. 1984. PMID: 6368960 Clinical Trial.

2

A randomized study of combination chemotherapy (VAC-FMC) with or without immunostimulation by Corynebacterium parvum in metastatic breast cancer.

Fritze D, Becher R, Massner B, Kaufmann M, Bruntsch U, Gallmeier WM, Mayr AC, Drings P, Abel U, Edler L, Jungi WF, Queisser W, Senn HJ. Fritze D, et al. Among authors: kaufmann m. Klin Wochenschr. 1982 Jun 15;60(12):593-8. doi: 10.1007/BF01711434. Klin Wochenschr. 1982. PMID: 7109499 Clinical Trial.

3

[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)].

Mayr AC, Senn HJ, Gallmeier WM, Bruntsch U, Becher R, Drings P, Fritze D, Kaufmann M, Queisser W, Kempgens U. Mayr AC, et al. Among authors: kaufmann m. Dtsch Med Wochenschr. 1979 Dec 7;104(49):1739-43. doi: 10.1055/s-0028-1129182. Dtsch Med Wochenschr. 1979. PMID: 510206 Clinical Trial. German.

4

Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.

Fritze D, Queisser W, Schmid H, Kaufmann M, Massner B, Westerhausen M, Schmidt R, Edler L, Abel U. Fritze D, et al. Among authors: kaufmann m. Onkologie. 1986 Dec;9(6):305-12. doi: 10.1159/000216041. Onkologie. 1986. PMID: 2950359 Clinical Trial.

5

A methodologically improved definition of chemosensitivity indices.

Abel U, Kaufmann M. Abel U, et al. Among authors: kaufmann m. Cancer Res. 1982 Apr;42(4):1610. Cancer Res. 1982. PMID: 7060032 No abstract available.

6

[Immunodiagnostic aspects of breast cancer (author's transl)].

Fritze D, Fritze J, Kaufmann M, Drings P. Fritze D, et al. Among authors: kaufmann m. Dtsch Med Wochenschr. 1978 Feb 17;103(7):306-8. doi: 10.1055/s-0028-1104427. Dtsch Med Wochenschr. 1978. PMID: 627193 German.

7

Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).

Kaufmann M, Jonat W, Abel U. Kaufmann M, et al. Recent Results Cancer Res. 1989;115:118-25. doi: 10.1007/978-3-642-83337-3_17. Recent Results Cancer Res. 1989. PMID: 2696024 Clinical Trial. No abstract available.

8

Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).

Jonat W, Kaufmann M, Abel U. Jonat W, et al. Among authors: kaufmann m. Recent Results Cancer Res. 1989;115:163-9. doi: 10.1007/978-3-642-83337-3_23. Recent Results Cancer Res. 1989. PMID: 2696028 Clinical Trial. No abstract available.

9

Adjuvant chemotherapy and venous thrombosis.

Kaufmann M, Lammers G, Fritze D, Kubli F. Kaufmann M, et al. J Cancer Res Clin Oncol. 1982;104(1-2):195-6. doi: 10.1007/BF00402068. J Cancer Res Clin Oncol. 1982. PMID: 7130246 No abstract available.

10

Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer.

Kaufmann M, Jonat W, Abel U, Hilfrich J, Caffier H, Kreienberg R, Trams G, Brunnert K, Schermann J, Kleine W, et al. Kaufmann M, et al. J Clin Oncol. 1993 Mar;11(3):454-60. doi: 10.1200/JCO.1993.11.3.454. J Clin Oncol. 1993. PMID: 8445420 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,362 results

Search Page